Deep Dive

Digital

An open call for innovation

There is a bright future ahead for open innovation in pharma, as Almirall executive vice-president, research and development chief scientific officer Karl Ziegelbauer explains.

Digital

Deep Dive: Digital Health 2021

There is no doubt that the COVID-19 pandemic has accelerated the adopt of digital health.

Patients

How the combination treatment challenge impacts patients and...

How the combination treatment challenge impacts patients

Deep Dive

Recruiting patients to increase diversity & inclusion in cli...

More so now than ever, the inclusion of more diverse, and often more relevant, study populations is gathering momentum within the clinical trial community.

Patients

How biomarkers and bioanalytics are changing R&D

Biomarkers have been causing a paradigm shift in how HCPs treat patients for some time – now they are bringing the pharma industry a new gold standard for clinical research.

Patients